Viewing Study NCT00871559


Ignite Creation Date: 2025-12-24 @ 2:58 PM
Ignite Modification Date: 2025-12-26 @ 1:59 PM
Study NCT ID: NCT00871559
Status: COMPLETED
Last Update Posted: 2014-03-26
First Post: 2009-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module